Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20631980rdf:typepubmed:Citationlld:pubmed
pubmed-article:20631980lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0001779lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0390423lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C1705845lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0011881lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0015264lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0034634lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C1332036lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C1366622lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:20631980lifeskim:mentionsumls-concept:C0910022lld:lifeskim
pubmed-article:20631980pubmed:issue11lld:pubmed
pubmed-article:20631980pubmed:dateCreated2010-9-29lld:pubmed
pubmed-article:20631980pubmed:abstractTextThe receptor for AGEs (RAGE) contributes to the development and progression of diabetic nephropathy. In this study, we examined whether the protective effects of RAGE blockade are exerted via modulation of the renal angiotensin II type 2 (AT2) receptor.lld:pubmed
pubmed-article:20631980pubmed:languageenglld:pubmed
pubmed-article:20631980pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20631980pubmed:citationSubsetIMlld:pubmed
pubmed-article:20631980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20631980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20631980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20631980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20631980pubmed:statusMEDLINElld:pubmed
pubmed-article:20631980pubmed:monthNovlld:pubmed
pubmed-article:20631980pubmed:issn1432-0428lld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:YamamotoHHlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:CooperM EMElld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:HussainTTlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:SamuelPPlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:WaltherTTlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:ThomasM CMClld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:ForbesJ MJMlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:AllenT JTJlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:BierhausAAlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:NawrothP PPPlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:CoughlanM TMTlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:KoitkaAAlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:SourrisK CKClld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:MorleyA LALlld:pubmed
pubmed-article:20631980pubmed:authorpubmed-author:PenfoldS ASAlld:pubmed
pubmed-article:20631980pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20631980pubmed:volume53lld:pubmed
pubmed-article:20631980pubmed:ownerNLMlld:pubmed
pubmed-article:20631980pubmed:authorsCompleteYlld:pubmed
pubmed-article:20631980pubmed:pagination2442-51lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:meshHeadingpubmed-meshheading:20631980...lld:pubmed
pubmed-article:20631980pubmed:year2010lld:pubmed
pubmed-article:20631980pubmed:articleTitleReceptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.lld:pubmed
pubmed-article:20631980pubmed:affiliationJDRF Einstein Centre for Diabetes Complications, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria, 8008, Australia. Karly.Sourris@bakeridi.edu.aulld:pubmed
pubmed-article:20631980pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20631980pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11596entrezgene:pubmedpubmed-article:20631980lld:entrezgene
entrez-gene:11609entrezgene:pubmedpubmed-article:20631980lld:entrezgene
entrez-gene:24182entrezgene:pubmedpubmed-article:20631980lld:entrezgene